Eric Lefkofsky Makes Mission A Reality By Helping Raise 80 Mil For Tempus

In recent events, Tempus Labs a Chicago based technology cancer research company has reached unicorn status well raising another whopping 80 million dollars. This unicorn funding of 80 million dollars has now set Tempus Labs at a total of 210 million dollars of funding raised towards cancer research. Tempus Labs frequently works alongside and with other cancer research foundations such as the Mayo Clinic and The University Of Chicago. Tempus labs uses modern technology equipment to find ways to personalize cancer treatment for patients and their loved ones. There are many different cancer research centers but Tempus takes a different approach than most by focusing on providing patients with quality care and more support than most of the other centers out there.

The Co-Founder of Tempus, Eric LefKofsky is well known for more than just his work with Tempus. He is most well known for his work with Groupon but he also founded the Lefkofsky Family Foundation alongside his wife. The Lefkofsky family foundation is a charitable cause that has been around since it was founded in 2006. Eric LefKofsky’s main goal and mission in everything he does is to enhance the quality of human life through all the work that he does. He has shown this mostly through his foundation and Tempus.

Tempus differs from other technology and cancer research organizations because they tend to focus more on patient experience and support rather than how much money they make. This is good because the last thing patients want to think about when going through a traumatic illness such as cancer is their financial ability to pay for their treatments. Over the last two years, Tempus has made a huge difference in the world of cancer research and patient treatment quality and they will continue to make a difference as they raise more money and add more employees to their team that have the same mission as Eric Lefkofsky does. So far Tempus is hiring about 30 new people per month and they have a little over 4,000 employees in total. Tempus can only go up to better things from here.

To Know More Click Here

Eric Lefkofsky Is Looking To Change The Medical World Through Startup Company, Tempus.

Eric Lefkofsky is an entrepreneur based out of Chicago who was thrust into the spotlight for his work on the website/application, Groupon. Known primarily for his ability to work with data, Lefkofsky has kept busy throughout his career in order to become one of the leading innovators within the Big Data side of the tech world. Now, Lefkofsky is making waves in the medical world thanks to his work on the startup company that he co-founded, Tempus. Tempus, which achieved Unicorn status this past year, is focused on fundamentally adjusting the way that patients and medical professionals interact with data in relation to cancer treatment.

Tempus was established in Chicago back in 2015 and since then the company has been on an almost meteoric ascension toward the top of the industry. Tempus has pushed toward a valuation of $1.1 billion which makes the company one of the few startups in Chicago to ever reach the vaunted ‘Unicorn’ status. Since Tempus was established, the cancer care company has managed to raise over $210 million in investment dollars with news breaking recently that Tempus has scored an additional $80 million through a string of investors. This latest round of investments came from New Enterprise Associates, Kinship Trust Co, T. Rowe Price Associates and Revolution Growth. Lefkofsky was ecstatic to see Tempus strike a chord with investors and he stated that Tempus was clearly amidst a “significant paradigm shift’.

Tempus seeks to create a digital overlay between medical records related to cancer care and the patients and medical professionals who needed to be able to access them. Tempus ports in data from all sources, even handwritten notes, in order to centralize the information into an easy-to-access database. One of the greatest hurdles that most medical professionals face when trying to treat patients suffering from cancer is simple: information. Cancer care is notoriously hard to dial in as each patient reacts differently to different routines. Having accessible information will allow patients and medical professionals to dial in a treatment plan that can maximize efficiency. Lefkofsky’s work with Big Data looks like it will pay off in a big way in a very important field.

To Read More Click Here

Eric Lefkofsky, Tempus, innovation in healthcare

Eric Lefkofsky, co-founder and Chairman of Groupon and Uptake technologies. Uptake Technologies is a software analytical platform which provides a tool that is used to allow companies to use their data to extract value. Mediaocena, Echo Global Logistics, InnerWorking, all use Uptake Technologies to help create use of data. Eric Lefkofsky began his path after graduating from the University of Michigan, and earning his Juris Doctor from the University of Michigan Law School. Eric Lefkofsky is a Trustee of Lurie Children’s Hospital of Chicago, the Art Institute of Chicago, and the Museum of Science and Industry also. Eric Lefkofsky is also the Chairman of the Board of Trustees of Chicago’s Steepenwolf Theater. Eric Lefkofsky is also co-founder of Lightbank, a venture organization of investors, who invests in distributive technologies. In 2006 Mr. Eric Lefkofsky and his wife Liz Lefkofsky founded the Lefkofsky Family Foundation. Lefkofsky Family Foundation is a private not for profit charity, who strives to add value that improves the quality of life of people in the communities by ensuring access to quality education in the hope of sparking innovative medical research, and human rights of women and girls in neglected communities and the expansion of cultural initiatives.

Eric Lefkofsky is also co0founder of Tempus. Tempus is an analytical health information technology cancer healthcare company. The healthcare industry is moving from traditional healthcare to the patient Centric healthcare. Tempus allows an environment that utilizes clinical data extracted from electronic health records and other healthcare data collecting tools that can be analyzed in order to create a customized form of healthcare based on real world data in order to create a unique set of healthcare procedures specific for the needs of the patients. Tempus, since 2015 has received investments totaling $210 million. Recently, Tempus received another $80 million investment. With the last $80 million investment, Tempus is now has a unicorn statues, worth approximately $1.1 billion.

To know more click: here.

Medical Solutions Made Possible Through Tempus, The Enterprise Co-Founded By Eric Lefkofsky

Eric Lefkofsky co-founded the enterprise, Tempus, which has been in the headlines for its groundbreaking medical approaches. Tempus is known for its molecular and clinical data collections and analyzation for the approach of furthering precision medicine. It has been responsible for the developement of solutions within the realms of treatments related to the eyes, skin, blood pressure and more.

Eric Lefkofsky is a well-respected Chicago entrepreneur who has co-founded not only Tempus, but Lightbank, Uptake Technologies, InnerWorkings, Echo Global Logistics and Mediaocean. He is also a trustee for The Museum of Science and Industry; the Lurie Children’s Hospital in Chicago; and the Art Institute of Chicago. He also serves as the Chairman of the Board of Trustees for the Chicago’s Steppenwolf Theatre Company.

Eric Lefkofsky and his wife, Liz, started the Lefkofsky Family Foundation to be an addition to the fight for advancing education initiatives, human rights, medicines, arts, and cultures of communities. He holds a Juris Doctor from the University of Michigan Law School.

Tempus has been specifically noted in the industry for its successful approach in medicine matters related to: gene therapy, gene editing and biotechnology for untreatable diseases. A list of solutions have made a big impact on medicine.

Voretigene Neparvovec-rzyl Medicine – approved by the US Food and Drug Administration. Created for the purpose of treating a hereditary vision loss that results from a gene alteration matter.

Atrial Fibrillation Diagnosis – KardiaBand smart phone watch, created by AliveCor, used to monitor a person’s heart rate and alert them in the instance of an outlier.

Skin Cancer Technology– a deep-learning algorithm formulated by a group of scientists at Stanford University to identify malignant and benign lesions.

Blood Pressure Monitoring – the first smartwatch to read blood pressure through radial artery occlusion. FDA approved.

Eye Disease Technology – said to be more accurate and cheaper than clinician diagnoses. A computer algorithm that groups retinal image data for screening purposes of eye diseases and much more.

For more information on either Eric Lefkofsky or Tempus, visit the Tempus website for further details. Website includes information on clinical products, clinical testings and even on how to get a job within the company.

To Read More Click Here

Beating Cancer Through Knowledge

Knowledge is power. Those who survive cancer do so because it was discovered early. They survive because they went to the hospital in time and had the right treatment administered. This happened because they had the knowledge. They had an idea what signs is a possible indication for cancer. Some of the people who do not survive don’t because they found out late.

Because of this, Cancer Treatment Centres of America, CTCA, is taking their fight against cancer a step forward. Instead of giving info to those who walk through their doors, they are reaching the whole world through WebMD. CTCA is dedicated to administering treatment to each of their patients and uses state of the art equipment to give supportive therapies. They have doctors who have years of experience in cancer treatment and care.

Getting a second opinion in regards to the treatment recommended is quite important. It allows both the patient and the care giver to be certain about the treatment recommended and opens them up to other options. There could be a possibility that the doctor only gave the options that could be handled by that particular hospital, having a second opinion could open you up to other advanced options that might give you a fighting chance.

Giving care to a cancer patient can be quite a challenge. No one cancer patient is the same as another. True, the symptoms are alike but their experiences differ. As a result, it is important that a care giver knows how to care for his or her patient. For this reason, it is important to have a reliable source of information. Someone who is an expert in giving care to cancer patients and has a wealth of information; like an expert from CTCA. Their partnership with WebMD will allow them to share the information they have with several care givers across the globe. If you are not in a position to walk into one of their facilities and have your questions answered, you can get a hold of one of the experts via WebMD.

In their partnership with WebMD, CTCA does not only seek to share their knowledge in the fight against cancer with patients and care givers alone. They also aim at sharing their knowledge with doctors as well. True, the best way to learn is through studying and practice. However, sharing.

To Know More Click Here


Why Eric Lefkofsky Co-Founded The Health Technology Firm Tempus

There’s a new Chicago, Illinois-based health technology company called Tempus, Inc. It was co-founded by entrepreneur Eric Lefkofsky in 2015 and the goal of this company is to help doctors treat cancer by providing them with cutting-edge technology. Tempus is already considered one of the most exciting health technology startups in America. It collaborates with universities and hospital across the nation as well as the National Cancer Institute.

Eric Lefkofsky was amazed when he learned how little data cancer doctors had available to them to treat cancer. If they could have access to a huge DNA and genomic database they would be able to individualize the care of patients to treat them in the way that they would best respond to, he thought. Tempus now provides this database to cancer doctors in numerous hospitals.

When Tempus was first established it garnered $130 million in funding to get it started. It is now already worth about $700 million. The platform they provide hospitals are giving physicians a way to make real-time decisions based on the best available data. Each patient who receives a whole genomic sequencing has their non-identifiable information added to the database which helps the next patient and so on.

Eric Lefkofsky has been a Chicago entrepreneur for almost 20 years. One of his biggest success was co-founding Groupon in 2007, a company that he is still the chairman of. This company famously offers its users local deals on products and services in their area. Another company he recently co-founded was Uptake which is a predictive analytics business.

In 2006, Eric Lefkofsky co-founded the Lefkofsky Family Foundation. This is an organization that is trying to make a global impact through sponsoring scientific research projects in the field of medicine, education, human rights, and the arts. They have supported many nonprofits over the years such as Teach For America, the Academy of Urban School Leadership, the American Civil Liberties Union, Human Rights Watch, The Aspin Institute, and the Whitney Museum of Art among many others. Their medical research donations have gone towards solving a host of diseases such as brain tumors and childhood diseases.

Learn More:

Dr. David Samadi Gives His Insight Regarding Prostate Surgery

In recent news, the former presidential nominee, Mitt Romney revealed that he had prostate surgery last summer to remove his prostate due to a diagnosis of prostate cancer. The surgery was performed by Dr. Thomas Ahlering at UC Irvine Hospital. This type of cancer is most common in men who are over the age of 65 and is reported to affect 164,690 individuals yearly. In addition to Mitt Romney, the former Secretary of State Colin Powell was also treated for prostate cancer in 2003. John Kerry also received the same diagnosis in 2002. He had prostate surgery and he has been clear of cancer ever since. When it comes to treatment for prostate surgery, there are usually two options for treatment. The patient can choose to have prostate surgery or they can elect to have radiation treatment.

According to Dr. David Samadi, he believes that Mitt Romney’s prognosis is good and he is not expected to develop further issues after his surgery. He goes on to say that after the staging of the cancer if the prostate cancer has not spread and is localized, he would recommend surgery as opposed to radiation. Dr. David Samadi also goes on to point out that statistically, if a man elects to have surgery if the cancer is localized, then he will have almost a 100% chance of survival as opposed to radiation, which gives the patient a 30% chance of survival if cancer spreads after treatment.

Dr. David Samadi is a world-renowned surgeon and is the and is in the top of his field in urology. He is also the Director of the Robotic Laparoscopic Surgery Department of Urology at Columbia Presbyterian Hospital. In his time working in the field of robotic surgery, has performed over 7,000 robotic surgeries. His specialty is the treatment of kidney, bladder, and prostate cancer. He also trains doctors to master the da Vinci robotic surgical system.

Dr. David Samadi has extensive experience and training. In the beginning of his professional career, he did his residency at Montefiore Medical Center in 1996 as well as Albert Einstein College of Medicine. He belongs the American Board of Urology and the American Urologic Association. In addition, he has also been featured in many national publications and television shows.

Contact Dr. David Samadi:

Cancer Treatment Centers Of America And NFLA Work To Screen Cancer

The National Football League Alumni Association cares about those who could be affected by cancer, and the organization is working with the Cancer Treatment Centers of America to help individuals learn if they are facing cancer or not. The two are working together to provide screenings to those men who feel that prostate cancer might be something that is a part of their lives. The NFLA and the Cancer Treatment Centers of America are offering a limited number of men the chance to be screened for prostate cancer without a charge. They are also providing men with the chance to pay for the screening if they are not a part of the first group who receive the screening for free.

The Cancer Treatment Centers of America work hard to help individuals who are facing cancer. With headquarters in Florida, this organization helps the whole country as it deals with the problem that is cancer. They help to not only fight cancer but to also deal with all of the side effects that can go along with it and all that those side effects bring into a person’s life.

There are multiple locations of the Cancer Treatment Centers of America. This is an organization that reaches those who are living in Illinois, Oklahoma, Pennsylvania, Arizona, and Georgia. This is an organization that is there for anyone faced with cancer, and it is an organization that is making a real difference in the lives of people all across the country.

Visit More :

Eric Lefkofsky’s Art of Giving and Making a Difference in People’s Lives

Americans have been spending a lot on health care due to increased charges and patients getting more intense, expensive care. Also, population growth and aging is also a cause for increased healthcare costs.

However, when one looks closely at every disease separately, you will find out that different factors have led to this increase in spending. Diabetes for instance, which had the highest charges, it was noted that t most amount of the money was spent on drugs. All said and done; there have been efforts to bring this figures down which have bore fruit. All of this, however, is important to enable future research on the value of health care spending.

CEO and Co-founder of Tempus, Eric Lefkosky is an American Entrepreneur. Moreover, Eric Lefkosky is the co-founder of Interworkings, Uptake, Mediaocean and Light Bank. Born on September 2, 1969, Detroit, Michigan, United States of America, Eric Lefkosky attended the University of Michigan where his career in business started.

It was in 2001 that he co-founded Interworkings. 4 years later, Eric Lefkofsky co-founded Global Logistics, a freight Logistics firm. In 2006, he co-founded MediaBank which later changed its name to Mediaocean. Eric then co-founded Light Bank in February 2010 and Uptake in 2014.

Eric Lefkofsky has been cited to be a man who is deeply concerned with cancer patients and is highly driven to help them. This is why in 2015 that Eric Lefkofsky co-founded Tempus. Tempus is simply a technology driven firm that enables physicians to offer personalized care to cancer patients.

Headquartered in Chicago, Illinois, Tempus basically, analyses large volumes of clinical and molecular data. This is all in a bid to come up with precise medicine to care for cancer patients.

Helping cancer patients is not all, Eric and his family are great philanthropists. In 2006, he started the Lefkosky Foundation. This is a foundation dedicated to supporting scientific, educational and organizations and causes across the globe. The Lurie’s Children Hospital is one of the organizations that has benefited from the foundation regarding health funding. Apart from health, education is also key in the Foundation’s agendas and truly they have been able to support over 17000 students in Chicago.

To Know More Click Here